Hindustan Unilever Ltd Share Price
(HINDUNILVR)
₹2367.9▲0.05%
as on 02:16PM, 17 Apr 2025
🔔 Legal Issues Alert
Hindustan Unilever Ltd has filed a lawsuit against Honasa Consumer for brand disparagement amid ongoing disputes over product claims.
HUL Performance
Day's Low
Day's High
₹2,343.1Day's Price Range₹2,379.952 Week's Low
52 Week's High
₹2,13652-Week Price Range₹3,035
| Returns % | |
| 1 Month Return | + 9 % |
| 3 Month Return | + 0.54 % |
| 1 Year Return | + 6.85 % |
| Market Stats | |
| Previous Close | ₹2,366.60 |
| Open | ₹2,365.20 |
| Volume | 15.45L |
| Upper Circuit | ₹2,603.20 |
| Lower Circuit | ₹2,130.00 |
| Market Cap | ₹5,56,054.27Cr |
HUL Fundamentals
P/E Ratio
51.75
PEG Ratio
28.43
Market Cap
₹5,56,054.27 Cr
P/B Ratio
10.46
EPS
43.75
Dividend Yield
1.85
Sector
FMCG
ROE
19.99
Mutual Fund Holdings of HUL
HUL Analyst Rating
based on 38 analysts
65.79%
Buy
28.95%
Hold
5.26%
Sell
Based on 38 analysts offering long term price targets for HUL. An average target of ₹2617.37
Source: S&P Global Market Intelligence
HUL Share analysis
HUL price forecast by 38 analysts
Upside of10.60%
High
₹3225
Target
₹2617.37
Low
₹1943
HUL target price ₹2617.37, a slight upside of 10.6% compared to current price of ₹2367.9. According to 38 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
HUL revenue growth forecast
Expected growth rate Q1, FY2027:15.01%
Forecast
Actual
Including amortisation and stock based compensations
HUL EPS growth forecast
EPS estimate Q1, FY2027:20.31%
Forecast
Actual
Source: S&P Global Market Intelligence
What's happening today
Today's Timeline - 17 Apr
06:34 AM
-HUL has filed a case in Bombay High Court against Honasa Consumer for disparaging its brand.
11:38 AM
-CLSA maintains Underperform rating on HUL, setting a target price of Rs 1943.
Key events for Hindustan Unilever Ltd
Hindustan Unilever Faces Legal Challenge from Honasa - 16 Apr, 2025
Hindustan Unilever is embroiled in a legal dispute with Honasa Consumer over a Lakmé sunscreen advertisement, which Honasa claims is misleading and disparaging. The Delhi High Court has noted the ad's potentially disparaging nature and sought a response from HUL.HUL Faces Criticism Amid Market Challenges - 15 Apr, 2025
Hindustan Unilever Ltd faces scrutiny from Honasa Consumer's co-founder over alleged plagiarism. HUL's sunscreen market share is significant, but growth shows signs of decline.HUL Reports Strong Profit and Dividend Announcement - 14 Apr, 2025
Hindustan Unilever Ltd announced a Rs 29 per share dividend, with a net profit of Rs 3,001 crore, a 19% YoY increase. Revenue grew 1.6% to Rs 15,818 crore. Despite a 15% decline over six months, the stock gained 8% annually and is up nearly 2% in 2025.Hindustan Unilever Declares Significant Dividend Payout - 13 Apr, 2025
Hindustan Unilever has announced a 2900% payout translating to Rs 29 per share. The board is expected to recommend a final dividend in Q4 results on April 24. HUL shares have seen a 4.5% increase over the past year, with a current dividend yield of 1.7%.Morgan Stanley Upgrades Hindustan Unilever Rating - 11 Apr, 2025
Morgan Stanley has upgraded Hindustan Unilever's rating to equalweight from underweight, projecting a 7% topline CAGR and 10% earnings growth for FY 2025-2027, with a new target price of ₹2,338.Hindustan Unilever Receives Positive Brokerage Outlook - 10 Apr, 2025
Hindustan Unilever submitted a regulatory compliance certificate for Q1 2025. Anand Rathi recommends accumulating the stock, highlighting its technical strength and potential upside.Analysts Bullish on Hindustan Unilever Stock - 09 Apr, 2025
Analysts are optimistic about Hindustan Unilever Ltd, recommending a buy with a target of ₹2,420 and a stop-loss at ₹2,200, citing bullish indicators.HUL Launches Climate Hub and Ice Cream Demerger - 08 Apr, 2025
Hindustan Unilever Limited has launched the Climate Incubation Hub with NSRCEL to foster climate innovations. Additionally, HUL plans to demerge its ice cream business into Kwality Walls for a separate listing.BofA Downgrades Hindustan Unilever Amid Slow Recovery - 02 Apr, 2025
BofA Securities downgraded Hindustan Unilever to Neutral, reducing the target price to Rs 2,330. The downgrade reflects slower-than-expected growth recovery and earnings pressure due to macroeconomic challenges.Leo Puri Resigns from Hindustan Unilever Board - 01 Apr, 2025
Leo Puri has announced his resignation from the board of Hindustan Unilever Limited, effective June 30, 2025, citing increased board commitments, including a potential global appointment.Rajneet Kohli Joins HUL as Foods Executive Director - 26 Mar, 2025
Hindustan Unilever Ltd has appointed Rajneet Kohli, former CEO of Britannia, as Executive Director of its foods division, effective April 7, 2025. Kohli brings over 28 years of experience and will join HUL's Management Committee, succeeding Shiva Krishnamurthy, who is leaving for other opportunities.HUL Expands Digital Presence Through Acquisitions - 25 Mar, 2025
Hindustan Unilever Ltd (HUL) is actively acquiring stakes in smaller digital-first brands to strengthen its market position and appeal to Gen Z consumers.Hindustan Unilever Board Meeting for Q4 Results - 24 Mar, 2025
Hindustan Unilever's board will meet on April 24, 2025, to approve Q4 financial results and discuss the final dividend recommendation. The company recently acquired Minimalist for Rs 2955 crore, approved by the CCI.Mariwala's FMCG Success Against Hindustan Unilever - 22 Mar, 2025
Mariwala has successfully established a strong FMCG business in India, previously turning the tables on Hindustan Unilever in the haircare market, despite competition from foreign multinationals.HUL Invests in Lucro Plastecycle for Sustainability - 20 Mar, 2025
Hindustan Unilever's board has approved the acquisition of a 14.3% stake in Lucro Plastecycle, aligning with its sustainability goals to enhance plastic recycling and support a zero-plastic-waste future.Hindustan Unilever Enhances Surf Excel Visibility - 19 Mar, 2025
Hindustan Unilever has increased the visibility of its Surf Excel brand by distributing cloth bags with compartments for wet and dry clothes at the Mahakumbh, addressing a common issue faced by attendees.
Insights on Hindustan Unilever Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 months, HINDUNILVR stock has moved up by 0.5%
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 5.77% to 6.08% in Dec 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 15.51K Cr → 16.55K Cr (in ₹), with an average increase of 2.1% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 2.59K Cr → 2.98K Cr (in ₹), with an average increase of 13.2% per quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 11.74% to 11.93% in Dec 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, Marico Ltd has given 42.3% return, outperforming this stock by 35.4%
- NO EFFECT
Against Peers
In the last 3 years, Godrej Consumer Products Ltd has given 56.3% return, outperforming this stock by 47.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 61.90% of holdings in Dec 2024 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 12.18% to 11.43% in Dec 2024 quarter
HUL News
Pharma Q4 Preview: Key Earnings Expectations for Major Companies
Overall estimated growth YoY basis: Revenue +8 to 10 percent | EBITDA +9 to 12 percent | PAT +1 to 2.7 percent. Aurobindo Pharma enters Q4FY25 with a more balanced outlook, as its long-troubled injectable business begins to show signs of recovery.17 Apr, 2025 10:41 AMAurobindo Pharma Receives USFDA Approval for Rivaroxaban Tablets
Aurobindo Pharma Limited announced that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Rivaroxaban Tablets USP, 2.5 mg, which is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), XARELTO®?, 2.5 mg of Janssen Pharmaceuticals Inc. The product will be launched in first quarter of fiscal year 26. The approved product, Rivaroxaban tablets USP, 2.5mg, has an estimated US market size of USD 447 million for the twelve months ending February 2025, according to IQVIA. Aurobindo Pharma now has a total of 540 ANDA approvals (521 Final approvals and 19 tentative approvals) from USFDA. Rivaroxaban Tablet USP is used (i) to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (ii) for the treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and for the reduction in the risk of recurrence of DVT and of PE (iii) for the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery. Aurobindo Pharma also received tentative approval from USFDA for 10 mg, 15 mg, and 20 mg strengths of Rivaroxaban Tablets UP. The estimated market size of all the strengths of Rivaroxaban tablets US P, in the US, is USD 8.5 billion for the twelve months ending February 2020, according to IQVIA.16 Apr, 2025 06:24 PMPharma Stocks Unfazed by US Investigation into Imported Drugs
Aurobindo Pharma Ltd in fact rose 0.40 per cent to Rs 1,139.65. It is the largest Indian generic company with US sales of $1.6 billion in Calendar 2024. Aurobindo Pharma has three manufacturing sites in the US, but the production and contribution from the sites are limited.16 Apr, 2025 09:55 AMHUL Financials
HUL Index Inclusions
HUL Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 61.9% | 0.00 | |
| Foreign Institutions | 11.43% | ||
| Mutual Funds | 6.08% | 5.45 | |
| Retail Investors | 11.93% | 1.63 | |
| Others | 8.65% | 2.87 |
HUL Key Indicators
HUL Valuation
HUL in the last 5 years
Lowest (47.18x)
March 4, 2025
Today (51.75x)
April 16, 2025
Industry (57.97x)
April 16, 2025
Highest (80.66x)
September 21, 2021
HUL Earnings and Dividends
Hindustan Unilever Ltd Earnings Results
Hindustan Unilever Ltd’s net profit jumped 18.93% since last year same period to ₹2,984Cr in the Q3 2024-2025. On a quarterly growth basis, Hindustan Unilever Ltd has generated 15.17% jump in its net profits since last 3-months.
Read More about Earnings ResultsHindustan Unilever Ltd Dividends October,2024
In the quarter ending September 2024, Hindustan Unilever Ltd has declared dividend of ₹19 - translating a dividend yield of 2.24%.
Read More about Dividends
HUL Technicals Summary
Bearish
Neutral
Bullish
Hindustan Unilever Ltd is currently in a Bullish trading position according to technical analysis indicators.
HUL Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹5,56,054.27 Cr | -0.15% | 0.56 | ₹10,282 Cr | ₹61,896 Cr | |
| HOLD | ₹69,399.85 Cr | 17.03% | 0.52 | NA | NA | |
| BUY | ₹1,27,323.57 Cr | 25.03% | 0.59 | -₹561 Cr | ₹14,096 Cr | |
| HOLD | ₹2,29,787.58 Cr | 7.51% | 0.75 | NA | NA | |
| BUY | ₹1,30,459.09 Cr | 18.25% | 0.69 | ₹2,134 Cr | ₹16,769 Cr |
About HUL
HUL's popular brands include Lux, Lifebuoy, Surf Excel, Rin, Sunsilk, Dove, Pond's, Fair & Lovely, Axe, Brooke Bond, Lipton, Bru, Knorr, Kissan, Kwality Wall's and Pureit. HUL is also the largest seller of tea in the country, with its popular brands such as Taj Mahal, Red Label, Taaza and Lipton. HUL has a strong presence across the country, with over 35,000 employees and a network of over 2.3 million retailers.
Revenue: ₹15,590.00Cr as on December 2024 (Q4 24)
Net Profit: ₹2,989.00Cr as on December 2024 (Q4 24)
Listing date: 03 Nov, 1994
Chairperson Name: Nitin Paranjpe
| Organisation | HUL |
| Headquarters | Mumbai |
| Industry | FMCG |
| E-voting on shares | Click here to vote |
FAQs on Hindustan Unilever Ltd
What is Hindustan Unilever Ltd price today?
Hindustan Unilever Ltd share price today stands at ₹2367.9, Open: ₹2365.2, Previous Close: ₹2366.6, High: ₹2379.9, Low: ₹2343.1, 52 Week High: ₹3035, 52 Week Low: ₹2136.
How to Buy Hindustan Unilever Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Hindustan Unilever Ltd shares
What are today's traded volumes of Hindustan Unilever Ltd?
Today's traded volume of Hindustan Unilever Ltd(HINDUNILVR) is 15.45L.
What is today's market capitalisation of Hindustan Unilever Ltd?
Today's market capitalisation of Hindustan Unilever Ltd(HINDUNILVR) is ₹556054.27Cr.
What is the 52 Week High and Low Range of Hindustan Unilever Ltd?
How much percentage Hindustan Unilever Ltd is down from its 52 Week High?
Hindustan Unilever Ltd (HINDUNILVR) share price is ₹2367.9. It is down -21.98% from its 52 Week High price of ₹3035
How much percentage Hindustan Unilever Ltd is up from its 52 Week low?
Hindustan Unilever Ltd (HINDUNILVR) share price is ₹2367.9. It is up 10.86% from its 52 Week Low price of ₹2136